Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293569.RAy1a3PzExAiD9vj-R9yKz8XaYpF2Y8wHq5Fgj7XJ2r-U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293569.RAy1a3PzExAiD9vj-R9yKz8XaYpF2Y8wHq5Fgj7XJ2r-U130_assertion type Assertion NP1293569.RAy1a3PzExAiD9vj-R9yKz8XaYpF2Y8wHq5Fgj7XJ2r-U130_head.
- NP1293569.RAy1a3PzExAiD9vj-R9yKz8XaYpF2Y8wHq5Fgj7XJ2r-U130_assertion description "[DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293569.RAy1a3PzExAiD9vj-R9yKz8XaYpF2Y8wHq5Fgj7XJ2r-U130_provenance.
- NP1293569.RAy1a3PzExAiD9vj-R9yKz8XaYpF2Y8wHq5Fgj7XJ2r-U130_assertion evidence source_evidence_literature NP1293569.RAy1a3PzExAiD9vj-R9yKz8XaYpF2Y8wHq5Fgj7XJ2r-U130_provenance.
- NP1293569.RAy1a3PzExAiD9vj-R9yKz8XaYpF2Y8wHq5Fgj7XJ2r-U130_assertion SIO_000772 26332453 NP1293569.RAy1a3PzExAiD9vj-R9yKz8XaYpF2Y8wHq5Fgj7XJ2r-U130_provenance.
- NP1293569.RAy1a3PzExAiD9vj-R9yKz8XaYpF2Y8wHq5Fgj7XJ2r-U130_assertion wasDerivedFrom befree-2016 NP1293569.RAy1a3PzExAiD9vj-R9yKz8XaYpF2Y8wHq5Fgj7XJ2r-U130_provenance.
- NP1293569.RAy1a3PzExAiD9vj-R9yKz8XaYpF2Y8wHq5Fgj7XJ2r-U130_assertion wasGeneratedBy ECO_0000203 NP1293569.RAy1a3PzExAiD9vj-R9yKz8XaYpF2Y8wHq5Fgj7XJ2r-U130_provenance.